In a groundbreaking new study published in Nature, researchers from the Weizmann Institute of Science, in collaboration with Sheba Medical Center and the Mayo Clinic, unveiled the first high-resolution genetic atlas of the healthy human liver at 2-micron precision. This unprecedented map reveals a far more intricate and nuanced division of labor in the human liver than what was previously understood. Their discoveries highlight why specific liver regions show differential vulnerability to diseases such as metabolic dysfunction and fatty liver disease, thus opening new avenues for targeted therapies.

The technological leap enabling this discovery comes from advances in single-cell RNA sequencing combined with spatial transcriptomics—techniques that allow scientists to identify gene activity in individual cells while precisely mapping their spatial context within the tissue. However, generating such a comprehensive map demanded access to exquisitely healthy tissue, a challenge overcome by studying liver samples from living donors who altruistically provided a part of their liver for transplantation. The liver’s unique regenerative ability enables these donors to remain healthy despite partial tissue removal. With contributions from surgical teams at Sheba Medical Center and the Mayo Clinic, eight samples from healthy donors were meticulously analyzed to create this detailed gene expression atlas.

Intriguingly, the new atlas disrupts the longstanding model that divided liver lobules into three functional zones based merely on nutrient and oxygen gradients. Instead, the researchers discovered eight distinct regions, each characterized by unique genetic signatures and metabolic roles. This fine-grained map enables scientists worldwide to investigate why diseases preferentially affect different lobule regions—for example, how metabolic diseases often originate near the lobule centers while viral and autoimmune inflammations tend to occur around the periphery. Moreover, the spatial atlas provides insights into the regional predisposition of liver cancers and metastatic tumors, linking cellular function to disease localization.

To elucidate evolutionary variations, the team compared the human liver atlas with analogous maps from mice, pigs, and cows. Interestingly, while blood flows from the lobule’s periphery to its center in all these mammals, resulting in oxygen and nutrient gradients, cellular activity patterns differ notably. In most mammals, cells near the lobule center exhibit lower metabolic activity due to resource scarcity. Humans, however, display a unique adaptation: central lobule cells maintain robust metabolic activity, engaging in functions such as fatty acid synthesis from excess energy, glucose production during fasting, toxin filtration, and bile secretion. This divergence may explain the human liver’s exceptional metabolic flexibility alongside its susceptibility to modern lifestyle diseases.

Another remarkable species-specific distinction centers on glucose handling within the liver. Often described as the body’s “fuel tank,” the liver optimally stores glucose during feeding and releases it during fasting. The study reveals that in humans, glucose uptake primarily occurs at the lobule centers, in stark contrast to mice where this activity is peripheral. This central localization allows for a highly efficient carbohydrate storage and release system, with peripheral cells converting lactate to glucose, thus complementing energy supply during fasting. While effective under natural dietary conditions, this system’s efficiency may paradoxically contribute to fat accumulation and liver fibrosis in response to today’s calorie-rich, fat-heavy diets.

To counterbalance the intense metabolic demands and resulting cellular stress, the human liver appears to have evolved a specialized mechanism for cellular turnover within the lobule centers. The study spotlighted Kupffer cells—specialized resident immune cells known for scavenging and recycling cellular debris. Unlike other mammals where Kupffer cells patrol the lobule periphery near blood entry points, in humans these cells concentrate at the lobule core. This strategic relocation likely helps manage the elevated cellular wear in this region, preventing tissue damage and maintaining liver homeostasis amid high metabolic throughput.

The practical implications of this atlas extend beyond basic biology into translational medicine. By comparing healthy liver cells with their counterparts in fatty liver disease—a condition tightly linked to obesity and diabetes—the researchers observed that cells accumulating fat initiate a defensive genetic program. They simultaneously downregulate genes involved in fat synthesis and uptake while upregulating genes promoting fat breakdown. Nonetheless, fat accumulation impairs mitochondrial function, reducing the organelles’ capacity to metabolize fats efficiently. Such molecular insights pave the way for targeted interventions that might reinforce these natural protective mechanisms or rectify their decline during disease progression.

Further integrating genetics with spatial information, the atlas allows precise pinpointing of zones most vulnerable to specific pathologies. This could revolutionize therapeutic development by enabling gene-targeted drugs or gene editing tools to focus on discrete lobule regions, minimizing off-target effects and maximizing efficacy. Moreover, the approach exemplified in this study—constructing single-cell-resolution genetic atlases from exceptional healthy donor tissue—sets a new standard for investigating human organs. Applied broadly, it promises to deepen our understanding of complex organ architectures and functions in health and disease.

In essence, the liver atlas represents a quantum leap in liver biology, shifting our perception from fuzzy, generalized zones to a vibrant, heterogeneous landscape of cellular specialization. This meticulous spatial and genetic dissection has profound implications for how we understand metabolism, immune defense, disease susceptibility, and regeneration in humans. By uncovering the liver’s secret organizational patterns, it also offers a fresh perspective on why human livers uniquely adapt to and sometimes falter under modern dietary pressures and metabolic challenges.

The study was spearheaded by Dr. Oran Yakubovsky alongside Prof. Shalev Itzkovitz and a multidisciplinary team spanning molecular biology, surgery, and computational analysis. Through their collaborative efforts, they leveraged innovative sampling approaches and sophisticated genomic technologies to deliver this illuminating atlas, ushering in a new era of precision hepatology.

Looking forward, the researchers envisage that their atlas will serve as a foundational resource for scientists probing liver diseases, drug metabolism, and regenerative medicine. The robust datasets and spatial frameworks provided could also facilitate artificial intelligence and machine learning applications aimed at modeling liver function and predicting disease course. Such integrative research holds the promise of transforming patient care, optimizing liver transplantation, and tailoring personalized therapies in hepatology.

This exciting accomplishment underscores how harnessing cutting-edge technology, clinical innovation, and human generosity can intersect to unravel the complex biology of vital organs. As techniques evolve, similar high-resolution atlases of other human organs may soon illuminate uncharted territories of cellular specialization, architectural nuances, and disease mechanisms, ultimately advancing medicine and human health.

Subject of Research: Spatial genetic mapping and functional zonation of the healthy human liver

Article Title: A spatial atlas of the healthy human liver from live donors

News Publication Date: 15-Apr-2026

Web References: https://www.nature.com/articles/s41586-026-10377-y

References: DOI 10.1038/s41586-026-10377-y

Keywords: liver atlas, spatial transcriptomics, single-cell RNA sequencing, lobule zonation, hepatocyte function, Kupffer cells, fatty liver disease, metabolic zonation, liver regeneration, glucose metabolism, mitochondrial dysfunction, human liver disease

Steatotic liver disease, encompassing a spectrum from simple fatty liver to non-alcoholic steatohepatitis (NASH), poses an escalating global health challenge due to its asymptomatic progression and potential to culminate in cirrhosis or hepatocellular carcinoma. Conventional diagnostic tools, primarily biopsy and two-dimensional ultrasound, face limitations either due to invasiveness or restricted spatial resolution. The cutting-edge 3D multiparametric ultrasound approach addresses these shortcomings by providing a comprehensive, non-invasive view of liver pathology with enhanced diagnostic accuracy.

At the heart of this innovation lies the fusion of three-dimensional volumetric imaging with multiple ultrasound-based parameters, including tissue stiffness, perfusion, and fat content assessment. This integrative methodology empowers clinicians and researchers to assess the liver’s structural and functional status simultaneously, thereby achieving a nuanced understanding of disease progression at an early stage. The technology’s multi-channel capability captures detailed acoustic signals, converting them into vivid 3D renderings that map the heterogeneity of hepatic tissue affected by steatosis.

The experimental validation of this technique was meticulously conducted using male rat models, carefully selected to replicate human steatotic liver conditions. These in vivo studies revealed the system’s capacity to identify subtle changes in liver morphology and function, inaccessible through standard imaging. Notably, the multiparametric ultrasound modality detected variations in echogenicity and elasticity correlating directly with the severity of lipid infiltration and inflammation within hepatic tissues.

One of the remarkable technical achievements of this study is the optimization of ultrasound probe design and signal processing algorithms, which together enable enhanced penetration depth and spatial resolution. These advances mitigate common issues such as acoustic shadowing and speckle noise, prevalent challenges in ultrasound imaging of obese or fatty liver tissues. The 3D reconstruction algorithms synthesize the multiparametric data sets into coherent volumetric images, facilitating both qualitative assessment and quantitative analysis with unprecedented precision.

The implications of this technology stretch beyond mere diagnostics. By accurately mapping steatotic regions and providing real-time feedback on tissue characteristics, this ultrasound platform paves the way for personalized therapeutic interventions. Clinicians can now monitor treatment efficacy dynamically, adjusting regimens based on direct imaging evidence of liver tissue response. This could fundamentally transform patient management, reducing reliance on invasive liver biopsy and enhancing long-term outcomes.

Moreover, the non-invasive nature and relative affordability of ultrasound compared to magnetic resonance imaging (MRI) or computed tomography (CT) make this innovation particularly appealing for widespread clinical adoption. Its ability to provide rapid, bedside assessments aligns perfectly with the growing push for point-of-care diagnostics in hepatology, especially in resource-limited settings where advanced imaging infrastructure is scarce.

The data acquisition protocol, meticulously refined during this study, ensures reproducibility and consistency across scans, a critical factor for longitudinal patient monitoring. By integrating sophisticated motion correction algorithms, the system compensates for respiratory and cardiac-induced liver movements, thus preserving image fidelity and reducing artifacts commonly encountered in ultrasound imaging.

Importantly, this multiparametric ultrasound imaging modality extends its utility to fundamental research contexts, offering new windows into the pathophysiology of steatotic liver disease. Researchers can study dynamic tissue changes and microvascular alterations associated with fat accumulation and inflammatory processes in vivo, accelerating the discovery of novel biomarkers and therapeutic targets.

The interdisciplinary collaboration underpinning this breakthrough involved experts in biomedical engineering, hepatology, and computational imaging, reflecting a paradigm where technological innovation converges with clinical necessity. The combination of engineering prowess and medical insight was crucial to overcoming the complex acoustic challenges posed by the liver’s heterogeneous, fatty tissue environment.

Through rigorous validation against histopathological findings, the imaging parameters extracted from the multiparametric ultrasound strongly correlated with established markers of hepatic steatosis and fibrosis. This correlation underscores the system’s potential as a surrogate for biopsy, enabling safer serial monitoring of disease progression or regression in response to lifestyle modifications or pharmacologic treatment.

Future iterations of this technology aim at integrating artificial intelligence-driven image analysis, automating segmentation, and classification of affected liver zones. Such enhancements would further reduce operator dependency and improve diagnostic throughput, facilitating scalable deployment in clinical settings worldwide.

The study’s findings represent a seminal step toward democratizing liver disease diagnostics, bridging the gap between advanced imaging science and practical, accessible healthcare solutions. As liver disease prevalence continues to rise globally due to lifestyle factors and metabolic syndromes, innovations like this 3D multiparametric ultrasound imaging technique could not be more timely.

In summation, the integration of three-dimensional imaging with multiparametric ultrasound parameters has inaugurated a new era in hepatology, promising safer, more accurate, and comprehensive assessment of steatotic liver disease. The potential to transform diagnostic pathways, personalize treatment, and deepen our understanding of liver pathologies positions this technology at the frontier of medical imaging innovation.

Lee et al.’s contribution to the field poignantly illustrates how sophisticated engineering solutions can translate into tangible clinical benefits, heralding a future where liver disease is detected earlier, managed more effectively, and ultimately, outcomes are vastly improved for millions afflicted worldwide.

Subject of Research:
3D Multiparametric ultrasound imaging for the evaluation of steatotic liver disease.

Article Title:
3D multiparametric ultrasound imaging of steatotic liver disease in a study with male rats.

Article References:
Lee, D., Heo, J., Mun, H. et al. 3D multiparametric ultrasound imaging of steatotic liver disease in a study with male rats. Nat Commun 16, 10226 (2025). https://doi.org/10.1038/s41467-025-65046-x

Image Credits:
AI Generated

DOI:
https://doi.org/10.1038/s41467-025-65046-x